The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Randomized study on the effect of zoledronic acid treatment for prostate cancer with bone metastasis during initial combined androgen blockade.
Satoru Ueno
No relevant relationships to disclose
Atsushi Mizokami
No relevant relationships to disclose
Mikio Namiki
No relevant relationships to disclose
Takashi Fukagai
No relevant relationships to disclose
Naohiro Fujimoto
No relevant relationships to disclose
Hitoshi Ooka
No relevant relationships to disclose
Yukihiro Kondo
No relevant relationships to disclose
Gaku Arai
No relevant relationships to disclose
Hisamitsu Ide
No relevant relationships to disclose
Kazuyoshi Kataoka
No relevant relationships to disclose
Kohei Kawaguchi
No relevant relationships to disclose
Masayoshi Shimamura
No relevant relationships to disclose
Matsuo Orito
No relevant relationships to disclose
Takeyuki Ishida
No relevant relationships to disclose
Daisuke Ikeda
No relevant relationships to disclose